down arrow

Aspen Aerogels, Inc.

  • Market Cap: Micro Cap
  • Industry: Other Industrial Products
  • ISIN: US04523Y1055
USD
3.63
0.15 (4.31%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

3.423.73

52 Week

2.9214.53
Valuation
Technical
Day's Volume

CASH

2.56 M

Shareholding (Mar 2025)

FII

7.75%

Held by 103 FIIs

DII

60.91%

Held by 41 DIIs

Promoter

0.00%

How big is Aspen Aerogels, Inc.?

22-Jun-2025

As of Jun 18, Aspen Aerogels, Inc. has a market capitalization of 488.12 million and net sales of 436.92 million, with a net profit of -286.04 million for the latest four quarters. Shareholder's funds are at 614.71 million and total assets at 895.14 million as of Dec 24.

As of Jun 18, Aspen Aerogels, Inc. has a market capitalization of 488.12 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 436.92 million, while the sum of net profit for the same period is -286.04 million.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds at 614.71 million and total assets at 895.14 million.

Read More

What does Aspen Aerogels, Inc. do?

22-Jun-2025

Aspen Aerogels, Inc. is an energy technology company that manufactures aerogel insulation for the energy infrastructure market. As of March 2025, it has net sales of $79 million, a market cap of $488.12 million, and a net profit of -$301 million.

Overview: <BR>Aspen Aerogels, Inc. is an energy technology company that designs, develops, and manufactures aerogel insulation, primarily serving the energy infrastructure market, and operates within the Other Industrial Products industry in the micro-cap bracket.<BR><BR>Financial Snapshot: <BR>Net Sales: 79 Million (Quarterly Results - Mar 2025) <BR>Net Profit: -301 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 488.12 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 13.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.15 <BR>Return on Equity: 12.28% <BR>Price to Book: 1.55<BR><BR>Contact Details: <BR>Address: 30 Forbes Rd Bldg B, NORTHBOROUGH MA: 01532-2501 <BR>Tel: 1 508 6911111 <BR>Fax: 1 508 6911200

Read More

Who are in the management team of Aspen Aerogels, Inc.?

22-Jun-2025

As of March 2022, the management team of Aspen Aerogels, Inc. includes Mr. William Noglows (Independent Chairman), Mr. Donald Young (President and CEO), and several independent directors: Ms. Rebecca Blalock, Mr. Robert Gervis, Mr. Steven Mitchell, Mr. Mark Noetzel, and Mr. Richard Reilly.

As of March 2022, the management team of Aspen Aerogels, Inc. includes the following individuals:<BR><BR>- Mr. William Noglows, Independent Chairman of the Board<BR>- Mr. Donald Young, President, Chief Executive Officer, Director<BR>- Ms. Rebecca Blalock, Independent Director<BR>- Mr. Robert Gervis, Independent Director<BR>- Mr. Steven Mitchell, Independent Director<BR>- Mr. Mark Noetzel, Independent Director<BR>- Mr. Richard Reilly, Independent Director<BR><BR>This team comprises a mix of executive leadership and independent directors.

Read More

Is Aspen Aerogels, Inc. overvalued or undervalued?

20-Sep-2025

As of May 8, 2025, Aspen Aerogels, Inc. is considered overvalued and risky, with a P/E ratio of 13 compared to the peer average of 29.81, an EV to EBITDA ratio of 6.03, and a significant underperformance of -71.95% over the past year.

As of 8 May 2025, the valuation grade for Aspen Aerogels, Inc. has moved from attractive to risky, indicating a shift in perception regarding its investment potential. The company appears to be overvalued, as evidenced by its P/E ratio of 13, which is significantly lower than the peer average of 29.81 for Montauk Renewables, Inc. Additionally, Aspen's EV to EBITDA ratio stands at 6.03, while its peers show higher valuations, further supporting the notion of overvaluation. The PEG ratio of 0.06 also suggests that the stock may not be justified at its current price.<BR><BR>In comparison to its peers, Montauk Renewables, Inc. has a P/E of 50.38, indicating a much higher market valuation relative to earnings, while Enviva, Inc. is also struggling with a risky valuation. Over the past year, Aspen Aerogels has seen a return of -71.95%, starkly contrasting with the S&P 500's return of 17.14%, highlighting the company's underperformance in the market. This combination of valuation ratios and poor stock performance suggests that Aspen Aerogels, Inc. is currently overvalued.

Read More

Is Aspen Aerogels, Inc. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, Aspen Aerogels, Inc. has shifted to a bearish trend with weak strength, indicated by bearish daily moving averages and a monthly MACD, while significantly underperforming the S&P 500 with a year-to-date return of -41.25%.

As of 12 September 2025, the technical trend for Aspen Aerogels, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength, indicated by the daily moving averages being bearish and the monthly MACD also showing a bearish signal. Although the weekly MACD and KST are mildly bullish, they are overshadowed by the overall bearish indicators. The stock has underperformed significantly compared to the S&P 500, with a year-to-date return of -41.25% versus the S&P 500's 12.22%, and a one-year return of -71.95% compared to 17.14% for the benchmark.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROE of 2.46%

  • The company has been able to generate a Return on Equity (avg) of 2.46% signifying low profitability per unit of shareholders funds
2

With a fall in Operating Profit of -58.5%, the company declared Very Negative results in Jun 25

3

Risky -

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Other Industrial Products

stock-summary
Market cap

USD 557 Million (Micro Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.09

stock-summary
Return on Equity

6.05%

stock-summary
Price to Book

1.80

Revenue and Profits:
Net Sales:
78 Million
(Quarterly Results - Jun 2025)
Net Profit:
-9 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-42.83%
0%
-42.83%
6 Months
-38.58%
0%
-38.58%
1 Year
-74.69%
0%
-74.69%
2 Years
-66.61%
0%
-66.61%
3 Years
-71.97%
0%
-71.97%
4 Years
-92.94%
0%
-92.94%
5 Years
-74.84%
0%
-74.84%

Aspen Aerogels, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Aspen Aerogels Hits 52-Week Low of $3.70 Amidst Major Decline

Aspen Aerogels Hits 52-Week Low of $3.70 Amidst Major Decline

Aspen Aerogels, Inc. has reached a new 52-week low, reflecting a challenging year marked by an 87.69% decline in stock price. The company reported a significant drop in operating profit and has experienced six consecutive quarters of negative results, raising concerns about its financial health and market position.

Read More
Aspen Aerogels Hits 52-Week Low at $4.08 Amidst Significant Decline

Aspen Aerogels Hits 52-Week Low at $4.08 Amidst Significant Decline

Aspen Aerogels, Inc. has reached a new 52-week low, reflecting a challenging year with an 86.89% decline in performance. The company reported a significant drop in both pre-tax and net profits, alongside low return on equity and a market capitalization of USD 557 million, indicating ongoing financial struggles.

Read More
Aspen Aerogels Forms Golden Cross, Signaling Potential Bullish Breakout

Aspen Aerogels Forms Golden Cross, Signaling Potential Bullish Breakout

Aspen Aerogels, Inc. has recently experienced a Golden Cross, indicating a potential shift in momentum. The stock shows a daily bullish trend in moving averages, suggesting increased investor interest. Despite a significant decline over the past year, recent short-term performance has shown signs of resilience.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
24.09%
EBIT Growth (5y)
35.82%
EBIT to Interest (avg)
-19.03
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.56
Tax Ratio
0.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
3.72%
ROE (avg)
2.46%
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
1.57
EV to EBIT
8.98
EV to EBITDA
6.03
EV to Capital Employed
1.67
EV to Sales
1.03
PEG Ratio
0.06
Dividend Yield
NA
ROCE (Latest)
18.58%
ROE (Latest)
12.28%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Bearish
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 64 Schemes (31.34%)

Foreign Institutions

Held by 103 Foreign Institutions (7.75%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -0.89% vs -36.07% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 96.98% vs -2,742.11% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "78.00",
          "val2": "78.70",
          "chgp": "-0.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.70",
          "val2": "3.50",
          "chgp": "120.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.10",
          "val2": "2.00",
          "chgp": "55.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.90",
          "val2": "-296.40",
          "chgp": "98.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.10",
          "val2": "-301.20",
          "chgp": "96.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.50%",
          "val2": "-37.30%",
          "chgp": "4.68%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 89.65% vs 32.32% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 129.26% vs 44.62% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "452.70",
          "val2": "238.70",
          "chgp": "89.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "89.40",
          "val2": "-31.00",
          "chgp": "388.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.00",
          "val2": "5.30",
          "chgp": "126.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-35.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13.40",
          "val2": "-45.80",
          "chgp": "129.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "143.50%",
          "val2": "-206.10%",
          "chgp": "34.96%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
78.00
78.70
-0.89%
Operating Profit (PBDIT) excl Other Income
7.70
3.50
120.00%
Interest
3.10
2.00
55.00%
Exceptional Items
-5.90
-296.40
98.01%
Consolidate Net Profit
-9.10
-301.20
96.98%
Operating Profit Margin (Excl OI)
9.50%
-37.30%
4.68%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -0.89% vs -36.07% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 96.98% vs -2,742.11% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
452.70
238.70
89.65%
Operating Profit (PBDIT) excl Other Income
89.40
-31.00
388.39%
Interest
12.00
5.30
126.42%
Exceptional Items
-35.10
0.00
Consolidate Net Profit
13.40
-45.80
129.26%
Operating Profit Margin (Excl OI)
143.50%
-206.10%
34.96%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 89.65% vs 32.32% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 129.26% vs 44.62% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Aspen Aerogels, Inc. stock-summary
stock-summary
Aspen Aerogels, Inc.
Other Industrial Products
Aspen Aerogels, Inc. is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions. Its product lines include Pyrogel and Cryogel. The Company provides Pyrogel XT/XT-E that reduces the risk of corrosion under insulation in high temperature operating systems; Pyrogel XTF, which provides protection against fire; Cryogel Z, which is designed for sub-ambient and cryogenic applications in the energy infrastructure market, and Spaceloft Subsea, which is used in pipe-in-pipe applications in offshore oil production. It also offers Spaceloft for use in building and construction market, and Cryogel X201, which is used in cold system designs consisting of refrigerated appliances, cold storage equipment and aerospace systems.
Company Coordinates stock-summary
Company Details
30 Forbes Rd Bldg B , NORTHBOROUGH MA : 01532-2501
stock-summary
Tel: 1 508 6911111
stock-summary
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."